These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17475676)

  • 1. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.
    Franco M; Martínez F; Quiroz Y; Galicia O; Bautista R; Johnson RJ; Rodríguez-Iturbe B
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R251-6. PubMed ID: 17475676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.
    Rodríguez-Iturbe B; Pons H; Quiroz Y; Gordon K; Rincón J; Chávez M; Parra G; Herrera-Acosta J; Gómez-Garre D; Largo R; Egido J; Johnson RJ
    Kidney Int; 2001 Jun; 59(6):2222-32. PubMed ID: 11380825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney.
    Franco M; Tapia E; Bautista R; Pacheco U; Santamaria J; Quiroz Y; Johnson RJ; Rodriguez-Iturbe B
    Am J Physiol Renal Physiol; 2013 Apr; 304(7):F982-90. PubMed ID: 23364804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.
    Quiroz Y; Pons H; Gordon KL; Rincón J; Chávez M; Parra G; Herrera-Acosta J; Gómez-Garre D; Largo R; Egido J; Johnson RJ; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2001 Jul; 281(1):F38-47. PubMed ID: 11399644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension.
    Franco M; Martínez F; Rodríguez-Iturbe B; Johnson RJ; Santamaría J; Montoya A; Nepomuceno T; Bautista R; Tapia E; Herrera-Acosta J
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1281-7. PubMed ID: 16868307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
    Bravo Y; Quiroz Y; Ferrebuz A; Vaziri ND; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F616-23. PubMed ID: 17567935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats.
    Rodríguez-Iturbe B; Quiroz Y; Nava M; Bonet L; Chávez M; Herrera-Acosta J; Johnson RJ; Pons HA
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F191-201. PubMed ID: 11788432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.
    Vanegas V; Ferrebuz A; Quiroz Y; Rodríguez-Iturbe B
    Kidney Int; 2005 Sep; 68(3):1161-70. PubMed ID: 16105047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
    Tian N; Gu JW; Jordan S; Rose RA; Hughson MD; Manning RD
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1018-25. PubMed ID: 17040973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells.
    Alvarez V; Quiroz Y; Nava M; Pons H; Rodríguez-Iturbe B
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1132-41. PubMed ID: 12372790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.
    Franco M; Tapia E; Santamaría J; Zafra I; García-Torres R; Gordon KL; Pons H; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    J Am Soc Nephrol; 2001 Nov; 12(11):2263-2271. PubMed ID: 11675402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats.
    Romero F; Rodríguez-Iturbe B; Parra G; González L; Herrera-Acosta J; Tapia E
    Kidney Int; 1999 Mar; 55(3):945-55. PubMed ID: 10027931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension.
    Deji N; Kume S; Araki S; Isshiki K; Araki H; Chin-Kanasaki M; Tanaka Y; Nishiyama A; Koya D; Haneda M; Kashiwagi A; Maegawa H; Uzu T
    Biochem Biophys Res Commun; 2012 Feb; 418(3):559-64. PubMed ID: 22293193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension.
    Satou R; Franco M; Dugas CM; Katsurada A; Navar LG
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension.
    Rodríguez-Iturbe B; Quiroz Y; Herrera-Acosta J; Johnson RJ; Pons HA
    J Hypertens Suppl; 2002 Jun; 20(3):S9-14. PubMed ID: 12184057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure.
    Pechman KR; Basile DP; Lund H; Mattson DL
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1234-9. PubMed ID: 18256138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
    Jiang S; Tang Q; Rong R; Tang L; Xu M; Lu J; Jia Y; Ooi Y; Hou J; Guo J; Yang B; Zhu T
    Eur J Pharmacol; 2012 Aug; 688(1-3):56-61. PubMed ID: 22609232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.
    Guan Z; Giddens MI; Osmond DA; Cook AK; Hobbs JL; Zhang S; Yamamoto T; Pollock JS; Pollock DM; Inscho EW
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F801-7. PubMed ID: 23269644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
    Mattar AL; Machado FG; Fujihara CK; Malheiros DM; Zatz R
    Clinics (Sao Paulo); 2007 Dec; 62(6):749-56. PubMed ID: 18209918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.